Discerning duplicate drug therapy is not the patient’s job

Patients don't want to understand cross-benefit coordination of therapy. They're trying to get well.

August 31, 2020

Related news

Perspectives

September 25, 2023

Specialty Drug Pipeline Quarterly Update: September 2023

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…

Perspectives

September 25, 2023

Traditional Drug Pipeline Quarterly Update: September 2023

This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…

Perspectives

September 25, 2023

Gene/Cell Therapy Quarterly Update: September 2023

This quarterly pipeline wrap-up provides a review of newly approved gene and cell…